Literature DB >> 21437314

The immunosuppressive side of PDT.

Pawel Mroz1, Michael R Hamblin.   

Abstract

Photodynamic therapy (PDT) is a promising novel therapeutic procedure for the management of a variety of solid tumors and many non-malignant diseases. PDT has been described as having a significant effect on the immune system, which may be either immunostimulatory or, in some circumstances, immunosuppressive. The immunosuppressive effects of PDT have nearly all been concerned with the suppression of the contact hypersensitivity reaction in mice. Here, we review the immunosuppressive aspects of PDT treatment and discuss some additional mechanisms that may be involved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21437314      PMCID： PMC3441049          DOI： 10.1039/c0pp00345j

Source DB:  PubMed          Journal:  Photochem Photobiol Sci        ISSN： 1474-905X            Impact factor:   3.982


  77 in total

Review 1.  Photodynamic therapy and anti-tumour immunity.

Authors:  Ana P Castano; Pawel Mroz; Michael R Hamblin
Journal:  Nat Rev Cancer       Date:  2006-07       Impact factor: 60.716

2.  Systemic suppression of the contact hypersensitivity by the products of protoporphyrin IX photooxidation.

Authors:  Alla A Kyagova; Galina V Mansurova; Lyudmila A Kozir; Gelii V Ponomarev; Vsevolod Y Pavlov; Igor O Konstantinov; Alexander Ya Potapenko
Journal:  Photochem Photobiol       Date:  2005 Nov-Dec       Impact factor: 3.421

3.  Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function.

Authors:  D I Gabrilovich; T Ishida; S Nadaf; J E Ohm; D P Carbone
Journal:  Clin Cancer Res       Date:  1999-10       Impact factor: 12.531

4.  IL-10 contributes to the inhibition of contact hypersensitivity in mice treated with photodynamic therapy.

Authors:  G O Simkin; J S Tao; J G Levy; D W Hunt
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

5.  Role of complement anaphylatoxin C3a in photodynamic therapy-elicited engagement of host neutrophils and other immune cells.

Authors:  Ivana Cecic; Jinghai Sun; Mladen Korbelik
Journal:  Photochem Photobiol       Date:  2006 Mar-Apr       Impact factor: 3.421

6.  Acute phase response induction by cancer treatment with photodynamic therapy.

Authors:  Mladen Korbelik; Ivana Cecic; Soroush Merchant; Jinghai Sun
Journal:  Int J Cancer       Date:  2008-03-15       Impact factor: 7.396

7.  Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain.

Authors:  Jean-Ehrland Ricci; Cristina Muñoz-Pinedo; Patrick Fitzgerald; Béatrice Bailly-Maitre; Guy A Perkins; Nagendra Yadava; Immo E Scheffler; Mark H Ellisman; Douglas R Green
Journal:  Cell       Date:  2004-06-11       Impact factor: 41.582

Review 8.  High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity.

Authors:  Marco E Bianchi; Angelo A Manfredi
Journal:  Immunol Rev       Date:  2007-12       Impact factor: 12.988

9.  Complement activation cascade and its regulation: relevance for the response of solid tumors to photodynamic therapy.

Authors:  Mladen Korbelik; Ivana Cecic
Journal:  J Photochem Photobiol B       Date:  2008-04-26       Impact factor: 6.252

10.  Role of cytokines in photodynamic therapy-induced local and systemic inflammation.

Authors:  S O Gollnick; S S Evans; H Baumann; B Owczarczak; P Maier; L Vaughan; W C Wang; E Unger; B W Henderson
Journal:  Br J Cancer       Date:  2003-06-02       Impact factor: 7.640
View more
  21 in total

1.  Immune response after photodynamic therapy increases anti-cancer and anti-bacterial effects.

Authors:  Eleonora Reginato; Peter Wolf; Michael R Hamblin
Journal:  World J Immunol       Date:  2014-03-27

2.  T-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it?

Authors:  Florian Anzengruber; Pinar Avci; Lucas Freitas de Freitas; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2015-06-11       Impact factor: 3.982

Review 3.  Chemotherapy and Physical Therapeutics Modulate Antigens on Cancer Cells.

Authors:  Wojciech Szlasa; Natalia Janicka; Natalia Sauer; Olga Michel; Bernadetta Nowak; Jolanta Saczko; Julita Kulbacka
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

Review 4.  Emerging concepts in designing next-generation multifunctional nanomedicine for cancer treatment.

Authors:  Kasturee Chakraborty; Archana Tripathi; Sukumar Mishra; Argha Mario Mallick; Rituparna Sinha Roy
Journal:  Biosci Rep       Date:  2022-07-29       Impact factor: 3.976

Review 5.  Porphyrin-based cationic amphiphilic photosensitisers as potential anticancer, antimicrobial and immunosuppressive agents.

Authors:  Nela Malatesti; Ivana Munitic; Igor Jurak
Journal:  Biophys Rev       Date:  2017-03-24

Review 6.  Photodynamic therapy induces an immune response against a bacterial pathogen.

Authors:  Ying-Ying Huang; Masamitsu Tanaka; Daniela Vecchio; Maria Garcia-Diaz; Julie Chang; Yuji Morimoto; Michael R Hamblin
Journal:  Expert Rev Clin Immunol       Date:  2012-07       Impact factor: 4.473

Review 7.  Understanding the connection between platelet-activating factor, a UV-induced lipid mediator of inflammation, immune suppression and skin cancer.

Authors:  Elisabetta Damiani; Stephen E Ullrich
Journal:  Prog Lipid Res       Date:  2016-04-09       Impact factor: 16.195

Review 8.  Immunological aspects of antitumor photodynamic therapy outcome.

Authors:  Małgorzata Wachowska; Angelika Muchowicz; Urszula Demkow
Journal:  Cent Eur J Immunol       Date:  2016-01-15       Impact factor: 2.085

9.  Photodynamic therapy plus regulatory T-cell depletion produces immunity against a mouse tumour that expresses a self-antigen.

Authors:  E Reginato; P Mroz; H Chung; M Kawakubo; P Wolf; M R Hamblin
Journal:  Br J Cancer       Date:  2013-09-24       Impact factor: 7.640

10.  Topical photodynamic therapy induces systemic immunosuppression via generation of platelet-activating factor receptor ligands.

Authors:  Matheus Ferracini; Ravi P Sahu; Kathleen A Harrison; Robert A Waeiss; Robert C Murphy; Sonia Jancar; Raymond L Konger; Jeffrey B Travers
Journal:  J Invest Dermatol       Date:  2014-07-22       Impact factor: 8.551
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.